Page 9 - Analyst Event News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Jan 11, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it is expanding its pipeline of innovative vaccines with three new development programs based on the clinical success of its infectious disease vaccine portfolio to date. This announcement reflects the Company’s commitment to accelerating its infectious disease portfolio based on Moderna’s experience with its COVID-19 vaccine. The development programs announced today are mRNA vaccine candidates...

Chip specialization and a single software layer to unite them all on December 15, 2020, 17:17 24 comments Something to look forward to: Intel made a number of intriguing disclosures and bold proclamations during last week’s Intel Analyst Day, highlighting how it sees its future evolving. What made the information even more intriguing—and frankly, more compelling—is that they did so while also offering a refreshing level of honesty and transparency about challenges they’ve faced. While the information about manufacturing delays at both their 10nm a...